Analysis of mutation of the cKit gene and PDGFRA in gastrointestinal stromal tumors

By                      

Experimental and Therapeutic Medicine, Vol. 10, Iss. 3, 2015-01 ,pp. : 1045-1051

Spandidos Publications

Access to resources Recommend Favorite

Recurrent gastrointestinal stromal tumor (GIST) of the stomach associated with a novel c-kit mutation after imatinib treatment

By Koyama Tomoki   Nimura Hiroshi   Kobayashi Katsutoshi   Marushima Hideki   Odaira Hironori   Kashimura Hirotaka   Mitsumori Norio   Yanaga Katsuhiko  

Gastric Cancer, Vol. 9, Iss. 3, 2006-08 ,pp. : 235-239

Springer Publishing Company

Access to resources Recommend Favorite

Surgical Management After Neoadjuvant Imatinib Therapy in Gastrointestinal Stromal Tumours (GISTs) with Respect to Imatinib Resistance Caused by Secondary KIT Mutations

By Haller Florian   Detken Sven   Schulten Hans-Jürgen   Happel Nicole   Gunawan Bastian   Kuhlgatz Jens   Füzesi László  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 526-532

Springer Publishing Company

Access to resources Recommend Favorite

Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia

By Al-Riyami Arwa Z.  

Leukemia and Lymphoma, Vol. 54, Iss. 8, 2013-08 ,pp. : 1788-1790

Informa Healthcare

Access to resources Recommend Favorite

Imatinib Mesylate: Targeted Therapy of Gastrointestinal Stromal Tumor

By  

Current Cancer Therapy Reviews, Vol. 1, Iss. 1, 2005-01 ,pp. : 93-108

Bentham Science Publishers

Access to resources Recommend Favorite